Skip to main content

Month: August 2021

ALR Technologies Advances Partnership Discussions with Two Global Animal Health Pharmaceutical Companies

SINGAPORE, Aug. 02, 2021 (GLOBE NEWSWIRE) — ALR Technologies SG Pte. Ltd. (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, announces today the advancement in partnership talks on the GluCurve Pet CGM with two key pharmaceutical companies in animal health. Subject to further due diligence and financial negotiations, one of the two will be selected as a strategic partner through purchasing a stake in the GluCurve Pet CGM. Joe Stern, Head of Animal Health at ALRT commented: “After receiving a great deal of interest, we have put other partnering opportunities for the GluCurve on hold because we believe the expertise, relationships, and global market reach these two pharmaceutical companies have will provide the most value to the veterinarians and pet owners who care for diabetic pets, along with our shareholders.” The...

Continue reading

SmartCard Marketing Systems Inc (OTC:SMKG) Partners with Compuage Infocom Ltd for Distribution of its 16+ E-Commerce, Cloud & Mobility Solutions With 12,000 Partners in the SAARC Region

New York, NY, Aug. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire— SmartCard Marketing Systems Inc (OTC:SMKG): Note: Access to 12,000 Resellers, Retailers, and System Integrators in the SAARC Region. Noteworthy: Recent spotlight has been focused on the company’s Visa Everywhere Fintech, Mumbai Gov’t Fintech JV, Axepay FX Cross-border Payment Rails, Chat Bot AI code library acquisition, OriginatorX – Ethereum Token Issuing & Patent Tokenization and Xpay Payment minority ownership. SmartCard Marketing Systems Inc (OTC:SMKG) with its 16+ proprietary solutions in E-Commerce, Cloud and Mobility is a leading Fintech and Paytech firm assisting enterprises with the digital transformation journey. This service is now extended to India through our partner and distributor – Compuage Infocom Ltd. India’s Micro...

Continue reading

Hydroxychloroquine Market 2021-2027 | To Reach USD 2,339.1 Million by 2027, Exhibit a CAGR of 5.5%

Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG Pune, India, Aug. 02, 2021 (GLOBE NEWSWIRE) — The global hydroxychloroquine market size is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will bode well for the market in the coming years. According to a report published by Fortune Business Insights, titled “Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027,” the market was worth USD 894.0...

Continue reading

BM Technologies (NYSE: BMTX) to Announce Q2 2021 Earnings and Host Webcast

Radnor, Aug. 02, 2021 (GLOBE NEWSWIRE) — BM Technologies, Inc. (NYSE American: BMTX), one of the largest digital banking platforms in the country, will release its Q2 2021 earnings after the market closes on August 11, 2021. The company will host a live webcast to discuss the earnings on August 12, 2021 at 9am EDT. Details related to accessing the webcast are forthcoming.  Contact Investor Relations: Bob Ramsey Chief Financial Officer, BM Technologies, Inc. (BMTX) 571-236-8851 rramsey@bmtx.com   # # #   About BM Technologies, Inc. (BMTX) BM Technologies, Inc. (NYSE American: BMTX)—formerly known as BankMobile—is among the largest digital banking platforms in the U.S., providing access to checking and savings accounts, personal loans, credit cards, and financial wellness. It is focused on technology, innovation, easy-to-use products,...

Continue reading

Sensei Biotherapeutics Appoints Kristian Humer to its Board of Directors

BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointment of Kristian Humer, former managing director of Banking, Capital Markets & Advisory for the Global Healthcare team at Citigroup, Inc. as an independent director to the company’s board of directors, effective July 30, 2021. Mr. Humer is currently chief financial officer and chief business officer of Viridian Therapeutics, which he joined in July 2021 after 11 years with Citigroup where he helped lead the firm’s investment banking engagements for small and mid-sized biopharma and select large cap pharmaceutical companies. “We are delighted to welcome Kristian to our board of directors. He brings global...

Continue reading

Nasdaq Acquires Minority Stake in LeveL ATS

NEW YORK and BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) and LeveL ATS today announced Nasdaq has acquired a significant minority stake in LeveL ATS, a leading, independently operated US Equity Dark Pool trading venue. Through this investment, Nasdaq joins owners including Bank of America, Citi, and Fidelity. The terms of the transaction were not disclosed. “As one of the most innovative and well recognized broker-neutral trading platforms across US equities, LeveL has demonstrated the ability to consistently meet the evolving needs of investors and serve as an important source of liquidity for its members,” said Tal Cohen, Executive Vice President and Head of North American Markets, Nasdaq. “We are pleased to join several leading sell-side firms to build on LeveL’s suite of products and current market position.” “In...

Continue reading

Rheumatoid Arthritis Testing Market Report 2021-2028 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast

Top Players Covered in the Rheumatoid Arthritis Testing Market Research Report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare GmbH, Microdrop LLC (imaware), Augurex Life Sciences Corp., Qiagen, Svar Life Science AB (Euro Diagnostica), Exagen Inc., Aviva Systems Biology Corporation, Bio-Rad Laboratories Inc and Other Market Players Pune, India, Aug. 02, 2021 (GLOBE NEWSWIRE) — The global rheumatoid arthritis testing market will derive growth from the high prevalence of the disease across the world. According to a report by Fortune Business Insights, titled “Rheumatoid Arthritis Testing Market Size, Share & Industry Analysis, By Test Type (Serological Tests, Rheumatoid Arthritis Severity Tests & Medication Monitoring Tests, Imaging Tests), By End User (Hospitals &...

Continue reading

Eledon Pharmaceuticals to Release Second Quarter Financial Results on Thursday, August 12, 2021

Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), today announced that it plans to release financial results for the second quarter ended June 30, 2021 on Thursday, August 12, after the close of trading. Eledon’s management team will host a conference call and webcast beginning at 4:30 pm ET. Conference Call and Webcast Details:Thursday, August 12, 2021 at 4:30 PM Eastern Time / 1:30 PM Pacific TimeToll Free: 877-407-9039 International: 201-689-8470 Conference ID: 13720793Webcast: https://ir.eledon.com/events-and-presentations/events After...

Continue reading

Publishing of Suominen’s Interim Report January–June 2021 on August 13, 2021

Suominen Corporation’s press release on August 2, 2021 at 3:00. p.m. (EEST) Suominen Corporation will publish its Interim report for January 1 – June 30, 2021 on Friday, August 13, 2021 at approximately 9:30 a.m. (EEST). Petri Helsky, President & CEO, and Toni Tamminen, CFO, will present the result in English in an audiocast and a conference call for analyst, investors and media on the same day at 11:00 a.m. (EEST). The audiocast can be followed at https://suominen.videosync.fi/2021-q2-results. The recording of the audiocast and the presentation material will be available after the event at www.suominen.fi. Conference call participants are requested to dial on:Sweden: +46 856642651 United Kingdom: +44 3333000804 United States: +1 6319131422  The confirmation code for joining the conference call is 21713834#. The event cannot be attended...

Continue reading

Hexatronic strengthens Australian market presence through acquisition of two leading telecom businesses

Hexatronic Group AB (publ) 556168-6360 Press Release August 2, 2021 Hexatronic strengthens Australian market presence through acquisition of two leading telecom businesses Hexatronic Group AB (publ) (“Hexatronic”) has today completed two acquisitions in Australia by acquiring 100% of the shares of Optical Solutions Australia Group Pty Ltd (“OSA”) as well as 100% of the shares of The Fibre Optic Shop Pty Ltd (“FOS”). OSA is a value-add distributor of a broad range of telecom products. FOS design, manufacture and distribute fibre optic management products. The combined enterprise value for the two businesses amounts to 47.4 MAUD, with an additional purchase consideration of up to 6.8 MAUD based on performance of the two entities. For both transactions, the fixed purchase price is paid partly in cash and partly through newly issued shares....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.